New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then, The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and commercialization FDA moves toward easing restrictions on certain peptides BioPharma Dive The wellness world is eager for RFK Jr.'s promised move on peptides : NPR